An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month.
from MobiHealthNews http://ift.tt/2F2Ig0A
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment